4.7 Article

Results from an IFCC global survey on laboratory practices for the analysis of circulating tumor DNA

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Multidisciplinary Sciences

Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges

Enrique Sanz-Garcia et al.

Summary: Circulating tumor DNA (ctDNA) is a widely applicable biomarker in cancer management. Changes in ctDNA levels over time, known as ctDNA kinetics, have the potential to serve as early indicators of therapeutic efficacy and allow for treatment adaptation. However, ctDNA kinetics are complex and heterogeneous, influenced by various factors.

SCIENCE ADVANCES (2022)

Article Oncology

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

J. Pascual et al.

Summary: Circulating tumour DNA (ctDNA) assays conducted on plasma are proving to be valuable tools for identifying actionable mutations in patients with advanced cancer and for detecting molecular residual disease or relapse in early-stage cancer. However, tissue-based testing is still preferred due to the limitations of ctDNA assays.

ANNALS OF ONCOLOGY (2022)

Review Medicine, Research & Experimental

Circulating tumor DNA: current challenges for clinical utility

Donna K. Dang et al.

Summary: Circulating tumor DNA (ctDNA) has become a predominant analyte for liquid biopsies, providing insights into the mutational landscape of cancer. It offers a relatively noninvasive approach compared to traditional tissue biopsies, allowing for simple repeated and serial assessments. While mostly used in metastatic diseases, ctDNA shows potential as a marker of minimal residual disease in curative settings and as a blood-based cancer screening tool.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Medical Laboratory Technology

Current and future challenges in quality assurance in molecular diagnostics

Parviz Ahmad-Nejad et al.

Summary: The development and performance of molecular genetic assays have led to increasingly complex quality assurance requirements, posing new challenges for quality management officers and technical personnel. Although quality control guidelines are not widely available, the ISO 15189 guideline can serve as a reference for integrating new test procedures.

CLINICA CHIMICA ACTA (2021)

Article Genetics & Heredity

Longitudinal Relationship between Idylla Plasma ctBRAF V600 Mutation Detection and Tumor Burden in Patients with Metastatic Melanoma

Mark William Linder et al.

Summary: This study investigated the relationship between changes in plasma ctDNA versus radiographic imaging among patients with metastatic melanoma. It found that ctDNA results corresponded to changes in CT imaging results, with a high correlation between qualitative and quantitative results, allowing for early detection of disease progression 55 and 97 days in advance.

MOLECULAR DIAGNOSIS & THERAPY (2021)

Review Oncology

Liquid Biopsy: From Discovery to Clinical Application

Catherine Alix-Panabieres et al.

Summary: CTC and ctDNA have been recognized as promising biomarkers with various clinical applications, including early cancer detection and therapeutic monitoring. However, challenges such as standardization and validation of clinical effectiveness need to be addressed in this dynamic field of translational cancer research.

CANCER DISCOVERY (2021)

Review Oncology

The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM-SIAPEC-IAP-SIBioC-SIC-SIF itallan Scientific Societies

A. Russo et al.

Summary: Liquid biopsy, utilizing various biological fluids as substitutes for neoplastic tissue to gather crucial information about tumors, is widely employed in clinical practice. Besides tumor tissue, other biological samples can also be used to identify predictive biomarkers for response or resistance to targeted treatments, with new applications emerging as useful clinical tools in the near future.

ESMO OPEN (2021)

Review Medical Laboratory Technology

Molecular and Functional Characterization of Circulating Tumor Cells: From Discovery to Clinical Application

Luis Enrique Cortes-Hernandez et al.

CLINICAL CHEMISTRY (2020)

Review Medical Laboratory Technology

Preanalytical variables that affect the outcome of cell-free DNA measurements

Vida Ungerer et al.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2020)

Review Biochemistry & Molecular Biology

Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms

Stefan Grabuschnig et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Pharmacology & Pharmacy

Cell-free DNA diagnostics: current and emerging applications in oncology

Penn Muluhngwi et al.

PHARMACOGENOMICS (2019)

Review Biochemistry & Molecular Biology

Circulating biomarkers for early detection and clinical management of colorectal cancer

Maria Marcuello et al.

MOLECULAR ASPECTS OF MEDICINE (2019)

Article Medical Laboratory Technology

Results of the first external quality assessment scheme (EQA) for isolation and analysis of circulating tumour DNA (ctDNA)

Verena Haselmann et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)

Article Multidisciplinary Sciences

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

Christopher Abbosh et al.

NATURE (2017)

Review Genetics & Heredity

Liquid Biopsies in Oncology and the Current Regulatory Landscape

Lindsay N. Strotman et al.

MOLECULAR DIAGNOSIS & THERAPY (2016)

Review Oncology

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy

Catherine Alix-Panabieres et al.

CANCER DISCOVERY (2016)

Review Medical Laboratory Technology

Circulating Tumor DNA as a Liquid Biopsy for Cancer

Ellen Heitzer et al.

CLINICAL CHEMISTRY (2015)

Article Multidisciplinary Sciences

Detection and quantification of rare mutations with massively parallel sequencing

Isaac Kinde et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Letter Medical Laboratory Technology

Changes in concentration of DNA in serum and plasma during storage of blood samples

M Jung et al.

CLINICAL CHEMISTRY (2003)